These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16981573

  • 1. [VALUE].
    Okura T, Higaki J.
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():419-24. PubMed ID: 16981573
    [No Abstract] [Full Text] [Related]

  • 2. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W.
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):41. PubMed ID: 15526662
    [No Abstract] [Full Text] [Related]

  • 3. [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct 27; 93(44):1836. PubMed ID: 15559910
    [No Abstract] [Full Text] [Related]

  • 4. Valsartan treatment of hypertension--does VALUE add value?
    Lindholm LH.
    Lancet; 2004 Jun 19; 363(9426):2010-1. PubMed ID: 15207946
    [No Abstract] [Full Text] [Related]

  • 5. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract] [Full Text] [Related]

  • 6. [CASE-J].
    Fukui T.
    Nihon Rinsho; 2006 Aug 17; 64 Suppl 6():449-53. PubMed ID: 16981578
    [No Abstract] [Full Text] [Related]

  • 7. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov 15; 149(46):53. PubMed ID: 18069196
    [No Abstract] [Full Text] [Related]

  • 8. [VALISH].
    Rakugi H, Ogihara T.
    Nihon Rinsho; 2006 Aug 15; 64 Suppl 6():454-8. PubMed ID: 16981579
    [No Abstract] [Full Text] [Related]

  • 9. [Study on cognition and prognosis in the elderly].
    Kohara K.
    Nihon Rinsho; 2006 Aug 15; 64 Suppl 6():425-30. PubMed ID: 16981574
    [No Abstract] [Full Text] [Related]

  • 10. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct 13; 93(42):1748. PubMed ID: 15529964
    [No Abstract] [Full Text] [Related]

  • 11. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M, Hollenberg NK.
    Am J Hypertens; 2004 Jul 15; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract] [Full Text] [Related]

  • 14. The VALUE trial: a commentary.
    Sever P.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 15; 5(3):99-101. PubMed ID: 15526243
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 15; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 17. [Type 2 diabetic patient with kidney damage. Sartans banish dialysis risk].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):56. PubMed ID: 15526676
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antihypertensive treatment and CHD in the elderly.
    Fink KS, Ellsworth A.
    Am Fam Physician; 1999 Sep 15; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.